Literature DB >> 12497075

Prognostic and treatment-predictive factors-is there a difference?

J Adolfsson1, G Steineck.   

Abstract

The terms risk factor, prognostic factor and predictive factor are often imprecisely used. We defined a prognostic factor as a patient characteristic that identifies subgroups of untreated patients having different outcomes, and a factor predictive of treatment effect as a patient characteristic that identifies subgroups of treated patients having different (as a consequence of treatment) outcomes. To illustrate this, theoretical graphical examples were constructed and data from the literature on prostate cancer were used to substantiate the theoretical examples. In most situations, but not necessarily always, a prognostic factor is also pre- dictive of the effect of specific treatments. Whether a prognostic factor is also predictive of treatment effect or not can only be assessed in a valid comparative setting such as in a randomized trial. A factor that is predictive for treatment effect may not be predictive for another treatment. Prostate Cancer and Prostatic Diseases (2000) 3, 265-268

Entities:  

Year:  2000        PMID: 12497075     DOI: 10.1038/sj.pcan.4500490

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  9 in total

1.  Q-Finder: An Algorithm for Credible Subgroup Discovery in Clinical Data Analysis - An Application to the International Diabetes Management Practice Study.

Authors:  Cyril Esnault; May-Line Gadonna; Maxence Queyrel; Alexandre Templier; Jean-Daniel Zucker
Journal:  Front Artif Intell       Date:  2020-12-17

2.  Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.

Authors:  Melissa A Wilson; Fengmin Zhao; Sanika Khare; Jason Roszik; Scott E Woodman; Kurt D'Andrea; Bradley Wubbenhorst; David L Rimm; John M Kirkwood; Harriet M Kluger; Lynn M Schuchter; Sandra J Lee; Keith T Flaherty; Katherine L Nathanson
Journal:  Clin Cancer Res       Date:  2015-08-25       Impact factor: 12.531

3.  Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Authors:  MinKe He; Qing Li; JingXian Shen; GuoSheng Tan; QiJiong Li; JiaYing Lai; Wei Wei; YaoJun Zhang; RuHai Zou; MinShan Chen; RongPing Guo; Ming Shi
Journal:  Cancer Med       Date:  2019-06-17       Impact factor: 4.452

Review 4.  Characterizing Exposure-Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects.

Authors:  Haiqing Isaac Dai; Yulia Vugmeyster; Naveen Mangal
Journal:  Clin Pharmacol Ther       Date:  2020-08-02       Impact factor: 6.875

5.  The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy.

Authors:  Natsuki Saigusa; Hideaki Hirai; Yuichiro Tada; Daisuke Kawakita; Masato Nakaguro; Kiyoaki Tsukahara; Satoshi Kano; Hiroyuki Ozawa; Takahito Kondo; Kenji Okami; Takafumi Togashi; Yukiko Sato; Makoto Urano; Manami Kajiwara; Tomotaka Shimura; Chihiro Fushimi; Akira Shimizu; Isaku Okamoto; Takuro Okada; Takayoshi Suzuki; Yorihisa Imanishi; Yoshihiro Watanabe; Akihiro Sakai; Koji Ebisumoto; Yuichiro Sato; Yoshitaka Honma; Keisuke Yamazaki; Yushi Ueki; Toyoyuki Hanazawa; Yuki Saito; Hideaki Takahashi; Mizuo Ando; Shinji Kohsaka; Takashi Matsuki; Toshitaka Nagao
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

6.  The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study.

Authors:  Gabor Liposits; Halla Skuladottir; Jesper Ryg; Stine Brændegaard Winther; Sören Möller; Eva Hofsli; Carl-Henrik Shah; Laurids Østergaard Poulsen; Åke Berglund; Camilla Qvortrup; Pia Osterlund; Julia S Johansen; Bengt Glimelius; Halfdan Sorbye; Per Pfeiffer
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

7.  Limited predictive value of illness perceptions for short-term poor recovery in musculoskeletal pain. A multi-center longitudinal study.

Authors:  E J de Raaij; H Wittink; J F Maissan; P Westers; R W J G Ostelo
Journal:  BMC Musculoskelet Disord       Date:  2021-06-07       Impact factor: 2.362

8.  Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.

Authors:  Ming-Yu Chen; Sarun Juengpanich; Jia-Hao Hu; Win Topatana; Jia-Sheng Cao; Chen-Hao Tong; Jian Lin; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2020-03-14       Impact factor: 5.742

Review 9.  Present status and future directions of intracanal medicaments.

Authors:  Ronald Ordinola-Zapata; W Craig Noblett; Alejandro Perez-Ron; Zhou Ye; Jorge Vera
Journal:  Int Endod J       Date:  2022-04-19       Impact factor: 5.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.